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The Hidden Steps of Domain Skipping:
Macrolactone Ring Size Determination
in the Pikromycin Modular Polyketide Synthase
The extent of the -carbonyl group reduction that pre-
cedes the next chain extension is determined by the
presence of a ketoreductase (KR), an enoyl reductase
(ER), and a dehydratase (DH) within the module. A thio-
esterase (TE) domain covalently linked to the final mod-
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Biochemical analysis of the erythromycin PKS2 Department of Medicinal Chemistry and
Institute for Structural Biology and Drug Discovery (DEBS1, DEBS2, and DEBS3) resulted in the develop-
ment of a model in which the DEBS multienzymes areVirginia Commonwealth University
800 East Leigh Street dimeric and each module interacts with its complement
in a helical arrangement that is both head-to-head andRichmond, Virginia 23219
head-to-tail [6]. Mutagenesis studies with the DEBS1
TE protein that contains active site mutations in individ-
ual KS, AT, and ACP domains have been used to modelSummary
the functional dimerization of polyketide synthases [7,
8]. Homodimeric complexes of these mutants failed toThe pikromycin (Pik) polyketide synthase (PKS) from
make the predicted triketide lactone product when pro-Streptomyces venezuelae comprises four multifunc-
vided with methylmalonyl-CoA as a substrate. However,tional polypeptides (PikAI, PikAII, PikAIII, and PikAIV).
specific heterodimeric complexes of these mutantsThis PKS can generate 12- and 14-membered ring
were functional, indicating that the mutations disruptedmacrolactones (10-deoxymethynolide and narbonol-
the catalytic activity of the complex and not the structureide, respectively) through the activity of its terminal
or dimerization. These efforts have demonstrated thatmodules (PikAIII and PikAIV). We performed a series
the KS domain within a module interacts with the ACPof experiments involving the functional replacement
on the complementary polypeptide, whereas the AT do-of PikAIV in mutant strains with homodimeric and het-
main can act on either ACP [7, 8].erodimeric PikAIV modules to investigate the details
Streptomyces venezuelae ATCC 15439 is known toof macrolactone ring size determination. The results
produce the 12-membered ring macrolides methymycin,suggest a new and surprising mechanism by which
neomethymycin, and novamethymyin [9] as well as thethe penultimate hexaketide chain elongation interme-
14-membered ring macrolides narbomycin and pikro-diate is transferred from PikAIII ACP5 to PikAIV ACP6
mycin (Figure 1). These 12- and 14-membered ring mac-before release by the terminal thioesterase domain.
rolides are derived from the aglycones, 10-deoxymethy-Elucidation of this chain transfer mechanism provides
nolide and narbonolide, respectively. A single PKSimportant new details about alternative macrolactone
containing four separate polypeptides (PikAI-PikAIV) isring size formation in modular PKSs and contributes
responsible for synthesis of the aglycone intermediates.to the potential for rational design of structural diver-
Initiation of polyketide biosynthesis by PikAI and elonga-sity by combinatorial biosynthesis.
tion through PikAIII provide hexaketide (1) and lead to
10-deoxymethynolide, whereas narbonolide production
Introduction requires an additional extension of the hexaketide chain
intermediate with methylmalonylCoA. This extension is
Polyketides are a diverse class of natural products that catalyzed by PikAIV and leads to heptaketide (2).
possess antibiotic, immunosuppressive, anti-cancer, The unique ability of the Pik PKS to generate 12- and
and other biological activities [1]. The synthesis of many 14-membered ring macrolactones presents an opportu-
of these compounds depends on the activity of modular nity to explore the fundamental processes of polyketide
polyketide synthases (PKSs), which are giant and com- synthesis, specifically the mechanistic details of the
plex multienzyme systems that catalyze the condensa- chain extension process and the flexibility of the TE
tion of simple carboxylic acids such as acetate and domain. Previous complementation experiments with a
propionate [2–5]. The enzymatic activities responsible mutant strain of S. venezuelae that expresses PikAIV
for each successive condensation reaction are physi- lacking a TE domain demonstrated that alternative ex-
cally grouped and have been designated “modules” [3]. pression of the final module determines macrolactone
Each module contains an acyl transfer (AT) domain that ring size [10]. Expression of full-length PikAIV [the last
loads an appropriate extender unit onto an acyl carrier module required for hexaketide (1) to heptaketide (2)
protein (ACP). The ketosynthase (KS) domain catalyzes chain elongation] generates the 14-membered ring mac-
a Claisen condensation between the extender unit and rolactone narbonolide, whereas expression of an N-ter-
the growing polyketide chain from the proceeding mod- minally truncated form of PikAIV (in which the alternative
ule, generating an ACP-bound -carbonyl intermediate. translation start codon 600 amino acids downstream of
the normal pikAIV start codon is used) results in synthe-
sis of the 12-membered ring macrolactone 10-deoxy-3 Correspondence: david-s@biosci.umn.edu
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Figure 1. The Structure and Biosynthesis of Methymycin, Neomethymycin, Novamethymycin, Narbomycin, and Pikromycin in S. venezuelae
Methymycin: R1  OH, R2  H; neomethymycin: R1  H, R2  OH; novamethymycin; R1  OH, R2  OH; narbomycin R3  H; pikromycin R3 
OH; the individual enzymatic domains in the multifunctional PKS protein. This figure uses the following abbreviations: ACP, acyl carrier protein;
KS, -ketoacyl-ACP synthase; KSQ, a KS-like domain; AT, acyltransferase; KR, -ketoacyl-ACP reductase (note the inactive KR domain in
PikAII); DH, -dehydratase; ER, enoyl reductase; TEI, thioesterase; TEII, type II thioesterase. Des represents all eight enzymes in desosamine
biosynthesis and transfer. PikC catalyzes the final hydroxylation reaction in the synthesis of methymycin, neomethymycin, novamethymycin,
and pikromycin.
methynolide. One hypothesis for this observation was Results and Discussion
that an interaction between PikAIII and an N-terminally
A PikAIV with Active KS6, AT6 and ACP6, and TEtruncated form of PikAIV enables the PikAIV TE to cata-
Domains Is Required for 10-Deoxymethynolidelyze the release of hexaketide (1) from the ACP5 domain
Biosynthesisof PikAIII. An alternative possibility is that the penulti-
Our initial investigation of the basis for macrolactonemate chain elongation intermediate (1) is transferred
ring size determination by the Pik PKS involved observa-(without elongation) and released directly from PikAIV
tions from a complementation study in the S. venezuelaeACP6 via the adjacent TE domain.
AX912 host strain. In AX912, the sequence encoding theIn a recent report based on studies with an engineered
TE domain of PikAIV was deleted (and replaced by 6XDEBS-based hybrid modular PKS, Leadlay and cowork-
His-Tag), resulting in loss of antibiotic production [10].ers observed a process whereby the polyketide chain
Transformation of AX912 with plasmids expressing the
elongation intermediate bypasses or “skips” an entire
Pik TE domain (pDHS704), the Pik ACP6-TE domainsmodule [11]. The Pik PKS might employ a similar process (pDHS705), and the Pik AT6-ACP6-TE domains (pDHS708)in which the hexaketide intermediate (1) undergoes resulted in the production of 10-deoxymethynolide and
transfer without extension or “skips” from PikAIII ACP5 narbonolide and led to the hypothesis that 10-deoxy-
to PikAIV ACP6 before its release. Herein, we report the methynolide biosynthesis resulted from heterodimer for-
results of an investigation designed to further elucidate mation between the chromosome-encoded PikAIV
the mechanism of macrolactone ring size determination (lacking a TE domain) and the plasmid-encoded forms
in a pikAIV deletion mutant of S. venezuelae by functional of PikAIV proteins (e.g., TE, ACP6-TE, AT6-ACP6-TE).
replacement experiments with native and mutant forms In the current study, we conducted additional comple-
mentation studies with the S. venezuelae strain HYK954of PikAIV (Pik module 6).
Domain Skipping in the Pikromycin PKS
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Figure 2. Chromosomal Arrangement of Pik PKS Genes in Wild-Type S. venezuelae and the pikAIV Strain, HYK954
In HYK954, the pikAIV gene has been replaced with the kanamycin resistance gene (aphII). The E. coli-Streptomyces shuttle vector pDHS4162
expresses pikAIV under the control of the PikAI promoter (PpikA) and restores production of both 10-deoxymethynolide and narbonolide.
This figure uses the following abbreviations: apr, apramycin resistance; SCP2*, Streptomyces origin of replication; colEI, E. coli origin of
replication.
mutant in which the entire pikAIV gene was replaced by In an effort to determine which Pik module 6 domain(s)
are required for the 10-deoxymethynolide biosynthesis,a kanamycin-resistance gene cassette (aphII) [12]. As
predicted, the HYK954 mutant produced no detectable we individually mutated the KS6, AT6, and ACP6 active
site residues of PikAIV. Specifically, the PikAIV KS6 do-levels of macrolide antibiotics. Production is fully re-
stored by transformation of the mutant strain with main active site Cys (C207A), the AT6 active site Ser
(S652A), and the Ser phosphopantetheinylation sitepDHS4162 (PikAIV(WT)) (Figure 2; [13]), but not by plas-
mids encoding the TE domain (pDHS704), ACP6-TE do- (S980A) in ACP6 were individually inactivated by site-
directed mutagenesis, yielding plasmids pDHS4176mains (pDHS705), and AT6-ACP6-TE domains (pDHS708)
of PikAIV (our unpublished data). S. venezuelae AX912 (KS), pDHS4179(AT), and pDHS4163(ACP), respec-
tively. In contrast to pDHS4162-expressing PikAIV (WT),transformants containing pDHS704, pDHS705, and
pDHS708 were grown under the same conditions as which completely restored antibiotic production to wild-
type levels in S. venezuelae HYK954, transformation ofcontrols, and partial restoration of macrolide biosynthe-
sis was observed as previously reported (Table 1; [10]). HYK954 with pDHS4176(KS), pDHS4179(AT), and
pDHS4163(ACP) failed to produce significant levels ofWe considered two explanations for the ability of
these plasmids to complement AX912 but not HYK954. either 12- or 14-membered ring macrolide compounds
by TLC or LC/MS analysis (data not shown). The inabilityFirst, the plasmid-encoded truncated PikAIV proteins
might require a unique interaction with AX912-encoded of these mutant forms of PikAIV to produce 12-mem-
bered ring macrolide derivatives in the HYK954 pikAIVPikAIV [KS6-AT6-ACP6] for TE-dependent release of hex-
aketide (1) from PikAIII ACP5. Alternatively, the PikAIII deletion mutant strain indicated an essential role for the
KS6, AT6, and ACP6 active site residues, consistent withhexaketide bound to ACP5 may “skip” to ACP6 of the
AX912-encoded PikAIV protein [KS6-AT6-ACP6], with the a “domain skipping” mechanism.
TE proteins (from the expression plasmids) catalyzing
subsequent chain release. It is also important to note Formation of Functional Heterodimeric PKSs
between Domain-Inactivated PikAIVfor these experiments and those reported previously
[14] that the proposed heterodimeric forms of PikAIV Polypeptides and a TE-Deleted PikAIV
Although the homodimeric forms of PikAIV(KS), PikAIVare functional, whereas neither the N-terminally (AT6-
ACP6-TE) nor the C-terminally truncated KS6-AT6-ACP6 (AT), and PikAIV(ACP) were unable to restore 12-
membered ring macrolactone formation in HYK954, wehomodimeric forms of PikAIV are able to generate 10-
deoxymethynolide. predicted that they would be capable of heterodimeriza-
Chemistry & Biology
578
Table 1. Aglycone Production in S. venezulae Strain Ax912
Production of aglycones 10-deoxymethynolide and narbonolide by strains grown on solid sporulation agar. Natural PikAIV domains are shown
in red, and domains from the tylosin cluster (Tyl) are shown in blue. Brackets indicate the general fusion sites of the catalytic domains and
are described in [12]. Yields were determined to be HPLC analysis with a standard curve derived for both 10-deoxymethynolide and narbonolide.
ND, not detected.
tion with TE-deficient PikAIV expressed in AX912 and domains from Pik module 6 and modules 13 and 14
from the rapamycin (Rap) PKS cluster demonstratedthat restoration of 10-deoxymethynolide production
would confirm the conformational stability of the site- that functional interactions could form between modules
containing domains from these two systems [14]. Fordirected mutants (Figure 3). Consistent with these pre-
dictions, pDHS4176 [PikAIV(KS)] restored production example, S. venezuelae strain SC1016 contains Rap
ACP14 in place of the PikAIV ACP6 domain, and the re-of 10-deoxymethynolide and narbonolide to levels that
are similar to that observed with pDHS4162 [PikAIV sulting hybrid module produces only the 12-membered
ring macrolactone 10-deoxymethynolide (Table 2, Line(WT)]. Transformation of AX912 with pDHS4179 [PikAIV
(AT)] and pDHS4163 [PikAIV(ACP)] also resulted in 1). In light of the current study, this result suggests that
substitution of the PikAIV ACP6 for Rap ACP14 does notrestoration of macrolactone levels, but with elevated 10-
deoxymethynolide production relative to narbonolide prevent the skipping of hexaketide (1) but does impair
extension of the chain with methylmalonyl-CoA. Either(Table 1). The overall production of aglycones was signif-
icantly higher in AX912 strains complemented with the incorporation of a unique linker region between the
AT6 and ACP14 domains or the identity of the ACP domainpDHS4176 [PikAIV (KS)], pDHS4179 [PikAIV(AT)], and
pDHS4163 [PikAIV(ACP)] than it was in AX912 strains disturbs the catalytic center formed by the dimerization
of monomers such that the hexaketide chain can skipcomplemented with plasmids pDHS704, pDHS705,
pDHS708 that express N-terminally truncated forms of (e.g., transfer) to the ACP6 domain via a flexible 4-phos-
phopantetheine group but not be extended. It is notablePikAIV (Table 1; compare lines 2–4 with lines 5–8).
In contrast, introduction of pDHS3007 expressing the that substitution of AT13 sequence from the Rap PKS
into PikAIV produced a hybrid capable of synthesizingterminal module (TylAV, module 7) from the tylosin PKS
cluster (GenBank accession number U78289) into AX912 both 10-deoxymethynolide and narbonolide, thus high-
lighting the importance of domain linker regions and/orresulted in only trace production of 10-deoxymethynol-
ide (Table 1, line 9). Similarly, pDHS3017 and pDHS3023 identity of the ACP in forming a fully functional module
[14]. It is not clear if the extension reaction fails in thethat provide the respective plasmid-based expression
of hybrid modules in which Pik KS6 and KS6-AT6 domains hybrid KS6-AT6[-ACP14]Rap-TE because the ACP domain
remains unprimed with a methymalonyl extender unitare substituted for the corresponding tylosin domains
(e.g., KS6-[AT7-ACP7-TE]Tyl and KS6-AT6-[ACP7-TE]Tyl) did as a result of poor communication between AT6 and
ACP14 or if the extender unit is loaded on the ACP butnot improve the production of 10-deoxymethynolide in
strain AX912 (Table 1, lines 10 and 11). not capable of reacting with the hexaketide chain on
the KS6 active site. In contrast, S. venezuelae strain
SC1017 in which PikAIV KS6-AT6-ACP6-TE has been ex-Formation of Functional Heterodimeric PKSs
between Domain-Inactivated PikAIV changed by Pik KS6-[AT14-ACP14]Rap-TE produces neither
10-deoxymethynolide nor the predicted 2-des-methyl-Polypeptides and an Inactive Engineered PikAIV
Containing an AT-ACP Domain Switch narbonolide [14]. Plasmid-based expression of this hy-
brid PikAIV in strain AX912, however, does lead to resto-In a recent study of molecular recognition parameters
in the Pik PKS, a series of hybrid modules comprising ration of macrolide production, demonstrating that this
Domain Skipping in the Pikromycin PKS
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Figure 3. Proposed Interactions Leading to Functional Heterodimers
Plasmids expressing wild-type PikAIV or site-directed mutants were introduced into S. venezuelae strain AX912 that expresses an inactive
PikAIV lacking the thioesterase domain.
apparent nonfunctional form of PikAIV can serve as a In the current study, the introduction of plasmids
pDHS704, pDHS705, and pDHS708 into S. venezuelaedonor for complementation experiments to investigate
the formation of active heterodimers from an inactive SC1017 did not result in recombinants that produce
significant levels of 10-deoxymethynolide or narbonol-homodimeric module.
Table 2. Aglycone Production in S. venezuelae Strains SC1016 and SC1017
Production of aglycones 10-deoxymethynolide and narbonolide by strains grown on solid sporulation agar. Natural PikAIV domains are shown
in red, and the AT14 and ACP14 domains from the rapamycin cluster (Rap) are shown in green. Brackets indicate the general fusion sites of
the catalytic domains and are described in [13]. Yields were determined to be HPLC analysis with a standard curve derived for both 10-
deoxymethynolide and narbonolide. ND, not detected.
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Figure 4. Proposed Mechanism of Narbonolide and 10-Deoxymethynolide Biosynthesis by PikAIV
The bold line indicates the major path of the polyketide chain through the individual domains of the terminal module. Transfer of the hexaketide
(1) covalently bound to the ACP5 domain of PikAIII to the KS6 domain of the full-length PikAIV results in elongation to the heptaketide (2) and
release as narbonolide. The N-terminally truncated form of PikAIV catalyzes the transfer of the hexaketide (1) from the ACP5 domain of PikAIII
to the catalytic cysteine residue in the PikAIV KS6 domain. Translocation of the hexaketide (1) to the PikAIV ACP6 domain on the complementary
polypeptide leads to release and cyclization to 10-deoxymethynolide. The dashed line indicates the possible intrapolypeptide transfer of the
chain elongation intermediate (1).
ide, in contrast with results from the AX912 strain. This produce both 10-deoxymethynolide and narbonolide,
but at reduced levels. SC1017 transformants containingobservation is consistent with previous suggestions that
KS6 and AT6 are important components for dimerization pDHS4179 [PikAIV(AT)] and pDHS4163 [PikAIV(ACP)]
produced higher levels of 10-deoxymethynolide, butof PikAIV polypeptides and are thus required for genera-
tion of significant levels of active heterodimers. Sub- neither narbonolide nor 2-des-methylnarbonolide was
detected (a similar shift compared with the same com-stantial levels of macrolide biosynthesis were observed
when SC1017 was transformed with plasmids that ex- plementation experiment in AX912). Although these site-
directed mutant forms of PikAIV were able to producepressed both PikAIV(WT) (pDHS4162) and PikAIV con-
taining mutations in KS6 (pDHS4176), AT6 (pDHS4179), high levels of aglycones in AX912, the reduced produc-
tion observed in SC1017 might reflect less efficient di-or ACP6 (pDHS4163) (Table 2). This result confirms that
KS6 is an important factor for dimerization and thus merization between PikAIV polypeptides containing a
single point mutation and Pik KS6-[AT14-ACP14]Rap-TEformation of functional PikAIV heterodimers. More im-
portantly, these results demonstrate that the PikAIV pro- than that between the same polypeptides and Pik KS6-
AT6-ACP6.teins carrying mutations in the KS, AT, and ACP domains
are able to generate active heterodimers both with the
PikAIV in SC1017 (KS6-[AT14-ACP14]Rap-TE) and with Mechanism of Skipping of the Hexaketide Chain
Elongation Intermediate (1) in S. venezuelaeAX912 (KS6-AT6-ACP6). In SC1017, 10-deoxymethynol-
ide and narbonolide production was comparable to that Our working model predicts that a homodimeric, N-ter-
minally truncated form of PikAIV accepts the hexaketideobserved with AX912 containing pDHS4162 (compare
Table 1, line 5 with Table 2, line 6). When pDHS4176 intermediate from PikAIII and is required for the majority
of 10-deoxymethynolide biosynthesis in a wild-type[PikAIV(KS)] was used to transform S. venezuelae
SC1017, the resulting recombinant strain was able to strain. The frequency of heterodimer formation between
Domain Skipping in the Pikromycin PKS
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Table 3. Bacterial Strains and Plasmids
S. venezuelae Strains Relevant Genotype Reference
WT (ATCC 15439) Complete pik and des gene clusters ATCC
HYK954 pikAIV; complete pikAV and expression of des genes this report
AX912 Deletion of sequence encoding the PikAIV TE domain and TEII. Deletion [10]
has polarity affect on des genes
SC1016 Chromosomal mutant in which ACP14 from Rap is substituted for ACP6; [14]
pikAV is polar on des genes
SC1017 Chromosomal mutant in which AT14-ACP14 from Rap is substituted for [14]
AT6-ACP6; pikAV is polar on des genes
Plasmids Description Reference
pDHS618 Low-copy number; E. coli-Streptomyces expression vector; AprR [18]
pDHS702 Low-copy number; E. coli-Streptomyces expression vector; AmpR TsR [18]
pLITMUS 28 E. coli cloning vector; AmpR NEB
pLZ51 pNJ1 cosmid containing pikAIV [5]
pDHS3007 pDHS618 derivative expressing TylGV, the terminal module from the [13]
tylosin cluster; AprR
pDHS3016 pDHS618 derivative expressing a hybrid module consisting of KS6 from [13]
PikAIV and AT7-KR7-ACP7-TE from TylGV, AprR
pDHS3023 pDHS618 derivative expressing a hybrid module consisting of KS6 AT6 [13]
from PikAIV and KR7-ACP7-TE from TylGV; AprR
pDHS4147 2.3 kb fo the 3 of pikAIV cloned into pLITMUS28 as a EcoRI-BamHI This report
fragment; AmpR
pDHS4172 2 kb of the 5 of pikAIV cloned into pLITMUS28 as a BglII-EcoRI fragment; This report
AmpR
pDHS4162 pDHS618 derivative expressing PikAIV(WT); AprR This report
pDHS4163 pDHS618 derivative expressing PikAIV(ACP); AprR This report
pDHS4175 pDHS702 derivative expressing PikAIV(WT); AmpR TsR This report
pDHS4176 pDHS702 derivative expressing PikAIV(KS); AmpR TsR This report
pDHS4179 pDHS618 derivative expressing PikAIV(ACP); AprR This report
pDHS4182 pDHS618 derivative expressing PikAIV(KS-AT-ACP); AprR This report
full-length and truncated PikAIV and the ability of such the observations of narbonolide biosynthesis require
that the chain-elongated product on ACP6 is cleaved bya heterodimer to synthesize either narbonolide or 10-
deoxymethynolide remains to be determined because a TE domain on the opposite polypeptide strand. The
model also requires that for some module skipping tothe expression of each form in the fermentation experi-
ments presented herein would be impossible to ascer- occur, it is sufficient to have the KS, AT, and ACP do-
mains present on just one polypeptide, whereas moretain. In the current study, homodimers of the pikAIV-
encoded site-directed mutants are nonfunctional, but efficient skipping occurs if domains on the other poly-
peptide are active (lines 5–8 versus line 9 of Table 1).the observed functionality of heterodimers allows us
to assess the activity of each catalytic domain in 10- As a further test for this hypothesis, we carried out a
complementation experiment with pDHS4182. In thisdeoxymethynolide biosynthesis. A heterodimer be-
tween the chromosomally expressed PikAIV KS6-AT6- experiment, the plasmid-based KS-AT-ACP-TE would
form a heterodimer with a hybrid PikAIV containing anACP6 in AX912 and any of the three pikAIV-encoded
site-directed mutants would comprise one thioesterase inactive AT domain (AT14). In this case, no significant
levels of either 10-deoxymethyolide or narbonolide weredomain and only one functional active site for either the
KS, AT or ACP domains. There would be two native observed.
The ability of the active site mutant forms of PikAIVcopies of each of the remaining catalytic domains.
Therefore, we constructed a mutant form of PikAIV with to synthesize normal levels of 12-membered ring prod-
ucts in AX912 and SC1017, but not HYK954, indicatesboth C207A and S980A substitutions and used this in
complementation studies with AX912. In this example, an essential role for the core catalytic domains in the
synthesis of 10-deoxymethynolide and is consistentthe heterodimer would contain one polypeptide with
native active site residues for the KS, AT, and ACP do- with the hexaketide being transferred to Pik ACP6 prior
to TE-dependent release. However, the mechanistic de-mains but no thioesterase and the complementary poly-
peptide with a TE domain but inactive KS and ACP tails of chain transfer from PikAIII ACP5 to PikAIV ACP6
remain unclear. Consideration of the normal activitiesdomains. When pDHS4182 was introduced into AX912,
a decrease in overall yield (15%) of macrolides was of these domains and the complementation results pre-
sented herein and elsewhere [7, 8] suggests that in aobserved relative to that observed in complementation
experiments with the plasmids expressing single point model involving a dimeric modular PKS, an individual
catalytic center consists of a KS domain and an ACPmutations in PikAIV. This decrease in yield along with a
shift toward 10-deoxymethynolide production (as ob- domain that are located on either the same or opposite
polypeptide chains. Previously it has been suggestedserved in complementation experiments) resulted in no
detectable levels of narbonolide (Table 1, line 9). In a that the KS domain works only on the ACP domain of
the opposite chain [8]. Elongation of the polyketide chainskipping model for 10-deoxymethynolide biosynthesis,
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requires translocation of the chain from the preceding perimental evidence suggests that more efficient re-
lease of the acyl chain is accomplished with a TE do-ACP domain to the KS domain, where condensation
with the extender unit attached to the 4-phosphopan- main at the C terminus of PikAIV that contains
catalytically competent KS, AT, and ACP domains. Thistetheine prosthetic group of the ACP in the same module
results in growth of the chain and its transfer between data is consistent with the majority of the hexaketide
chain intermediate being transferred to the PikAIVproteins in the dimer. In 10-deoxymethynolide biosyn-
thesis, the interaction between PikAIII and the N-ter- ACP6 domain prior to release and cyclization to 10-
deoxymethynolide. A more thorough understanding ofminally truncated PikAIV allows the polyketide chain to
be translocated via the flexible 4-phosphopantetheine this mechanism will contribute to our overall knowl-
edge of polyketide chain transfer mechanisms as wellgroup from PikAIII ACP5 to the catalytic cysteine of KS6
(possibly exposed by the N-terminal truncation). Move- as to the development of novel termination activities
for combinatorial biosynthesis.ment of the ACP6 4-phosphopantetheine group, pre-
sumably lacking the methylmalonyl CoA extender unit,
Experimental Procedurestoward the “loaded” cysteine of KS6 may allow direct
thiol transfer of the hexaketide to the ACP either on
Bacterial Strains and Culture Conditions
the same or on the opposite polypeptide in the dimer E. coli DH5was used as a host for the manipulation of plasmid DNA.
complex. The activity of the TE in an interpolypep- Wild-type Streptomyces venezuelae ATCC 15439 and the derivative
tide-, and possible intrapolypeptide-, catalyzed reaction mutant strains HYK954, AX912, SC1016, and SC1017 have been
described previously [10, 13, 14]. Plasmids and S. venezuelae strainscleaves the ACP6 bound hexaketide product to generate
used as production hosts for the engineered expression plasmids10-deoxymethynolide (Figure 4). The translocation of
in this study are summarized in Table 3. S. venezuelae transformantsthe hexaketide from PikAIII ACP5 through KS6 to PikAIV
were grown on R2YE agar plates and then transferred to sporulation
ACP6 appears to require the activity of the AT6 domain. agar for production of spores and antibiotics.
This result is consistent with previous conclusions that
the identity and/or activity of the AT domain is an impor- Construction of Complementation Vectors
tant structural determinant for facilitating TE-catalyzed Complementation vectors are all derivatives of pDHS702 and
pDHS618, which both contain Streptomyces SCP2* low-copy originproduction of 10-deoxymethynolide [14]. It is worth not-
[15] and an E. coli colE origin and use the pikAI promoter to expressing, however, that in a complementation study with
gene inserts. Derivatives of these plasmids were transformed intoSC1017 and pDHS4179, the heterodimer containing an
S. venezuelae by the standard protoplast transformation procedure
AT6 mutant and RapAT14-containing PikAIV (which is not [16]. Plasmids were selectively maintained in S. venezuelae with
functional as homodimeric PikAIV) produces signifi- thiostrepton (pDHS702 derivatives) and apramycin (pDHS618 deriv-
cant levels of 10-deoxymethynolide. This observation is atives) at a concentration of 25 g/ml. Manipulation of plasmid DNA
was performed by standard cloning procedures, and polymeraseconsistent with a mechanism in which skipping of the
chain reaction (PCR) amplification was performed with the pfu poly-hexaketide chain to the ACP6 domain requires a 4-phos-
merase (Stratagene) under conditions recommended by the manu-phopantetheine group that is not loaded with a meth-
facturer. The 3 end of the pikAIV gene was cloned as a 2.3 kb
ylmalonyl extender unit. The structural or catalytic role EcoRI-BamHI fragment from pLZ51 into pLITMUS28 (New England
of AT6 in the production of 10-deoxymethynolide is an Biolabs) to yield pDHS4147. The 5 end of pikAIV was generated as
important component of our continued analysis of the a 2.4 kb BglII-EcoRI fragment, was amplified from pLZ51 with the
primers 5-AAAAGATCTGACCCGACCGCGGTCCTGCCCCA-3 andspecific biochemical details of the domain-skipping
5-GGCGGCGAATTCGGGTGAGCTGTC-3, and was cloned intomechanism.
pLITMUS to yield pDHS4172. The BglII-EcoRI insert from pDHS4172
and an EcoRI-XbaI insert from pDHS4147 were cloned into
pDHS4618 that had been digested with BamHI and XbaI to yield
Significance pDHS4162. The pDHS4175 plasmid was constructed in a similar
manner except that the EcoRI-XbaI insert from pDHS4147 was first
Polyketides are a structurally diverse class of com- cloned into pUC118 so that the fragment could be digested with
EcoRI-PstI and cloned into the NsiI site of pDHS702.pounds that have been developed as pharmaceuticals
Site-directed mutagenesis of the active site residues in the pikAIVfor the treatment of cancer and infection. The synthe-
KS, AT, and ACP domains was accomplished by standard PCRsis of many of these compounds depends on the activ-
methodologies and confirmed by DNA sequencing. The plasmid
ity of modular polyketide synthases (PKSs) that elon- pDHS4163 expresses a mutant form of pikAIV in which the sequence
gate simple carboxylic acids as intermediates bound encoding the ACP active site sequence has been changed to GAT
to separate acyl carrier proteins (ACPs). The naturally GCA TTG, creating a diagnostic NsiI site and resulting in a S980A
mutation. Plasmid pDHS4176 expresses a mutant form of PikAIV inoccurring pikromycin polyketide synthase from Strep-
which the sequence encoding the KS catalytic cysteine has beentomyces venezuelae contains four polypeptides (PikAI-
changed to GCG GCT ACG, creating a diagnostic NheI site andPikAIV) and has the unique ability to generate 12- and
resulting in a C207A mutation. Plasmid pDHS4179 expresses a mu-
14-membered ring macrolactones, 10-deoxymethy- tant form of PikAIV in which the sequence encoding the AT active
nolide and narbonolide, respectively, by the activity of site serine has been changed to CAT GCG CAG, creating a diagnos-
the thioesterase domain located in the terminal mod- tic FspI site that results in a S652A mutation. Plasmid pDHS4182
expresses a mutant form of PikAIV containing both C207A andule, PikAIV. Extension of the hexaketide chain interme-
S980A substitutions.diate from PikAIII by PikAIV leads to formation of the
14-membered ketolide ring narbonolide, whereas re-
Purification and Characterization of Polyketide Productionlease of the hexaketide results in the formation of 10-
Production of pikromycin-related polyketides was determined on
deoxymethynolide. While some interaction between solid phase medium. Spore suspensions were spread onto 25 ml
PikAIII and an individual TE domain can allow for direct of sporulation agar containing appropriate antibiotics and were
grown at 30	C for 3 days. The agar was first extracted with 50 mlrelease of the hexaketide from the ACP5 domain, ex-
Domain Skipping in the Pikromycin PKS
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of methanol for 1 hr. The dried extract was dissolved in 25 ml of M.J. (1986). Construction and characterization of a series of
multi-copy promoter-probe plasmid vectors for Streptomyceswater and then extracted with 25 ml of ethyl acetate. The dried
ethyl acetate extract was resuspended in 500 l of acetonitrile for using the aminoglycoside phosphotransferase gene from Tn5
as indicator. Mol. Gen. Genet. 203, 468–478.analysis. For silica thin-layer-chromatography analysis, the agly-
cone compounds were separated with a chloroform: methanol (95:5) 13. Yoon, Y.-J., Beck, B.J., Kim, B.-S., Kang, H.Y., Reynolds, K.A.,
and Sherman, D.H. (2002). Generation of multiple bioactive mac-solvent, and the glycosylated/hydroxylated products were sepa-
rated with a chloroform:methanol: 25% NH4OH (90:10:1) solvent. All rolides by hybrid modular polyketide synthases in Streptomyces
venezuelae. Chem. Biol., 9, 203–214.compounds were visualized by vanillin staining and heating [17].
HPLC analysis of extracts allowed quantitative comparison of po- 14. Chen, S., Xue, Y., Sherman, D.H., and Reynolds, K.A. (2000).
Mechanisms of molecular recognition in the pikromycin polyke-lyketide production between strains. Sample extracts were injected
into a C-18 reverse-phase HPLC analytical column (250 mm 
 4.6 tide synthase. Chem. Biol. 7, 907–918.
15. Lydiate, D.J., Malpartida, F., and Hopwood, D.A. (1985). Themm, 10 m particle size) and eluted with a 30 min gradient of 50%–
90% acetonitrile buffered with 10 mM ammonium acetate (pH 9.0). Streptomyces plasmid SCP2*: its functional analysis and devel-
opment into useful cloning vectors. Gene 35, 223–235.Peak areas were integrated compared to a standard curve gener-
ated with purified compounds. Antibiotic production was averaged 16. Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood,
D.A. (2000). Practical Streptomyces Genetics. (Norwich, En-from at least three separate S. venezuelae transformants.
gland: The John Innes Foundation).
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